4//SEC Filing
Hansen Gwenn 4
Accession 0001817160-25-000003
CIK 0001549595other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 7:04 PM ET
Size
5.9 KB
Accession
0001817160-25-000003
Insider Transaction Report
Form 4
Hansen Gwenn
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2025-10-14+20,000→ 20,000 totalExercise: $0.00→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs will vest on the second anniversary of the date of grant, subject to the Reporting Person's continuous services to the Issuer from the date of grant through such vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- [F3]RSUs do not expire; they either vest or are canceled prior to the vest date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001817160
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 7:04 PM ET
- Size
- 5.9 KB